GSTM1 and anemia: Participants with anaemia (Hb < 10.5 g/dL) at ± 22 weeks’ gestation had 2.15 times higher odds of having elevated MAP than women without anaemia (OR: 2.15, 95% CI: 1.01 4.60) in model 2 (Table 3b).